PharmAbcine Inc. Logo

PharmAbcine Inc.

Develops antibody therapies for cancer, eye diseases, and vascular-related disorders.

208340 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 유성대로1689번길 70 KT대덕2연구센터 연구2동 2층, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PharmAbcine Inc. is a clinical-stage biotechnology company founded in 2008, specializing in the development of novel antibody therapeutics. The company leverages its proprietary fully human antibody library and discovery platforms to create next-generation, IgG-based monoclonal antibody (mAb) candidates. Its development pipeline focuses on treatments for cancer, neovascular eye diseases, and other vascular-related disorders. PharmAbcine's business model centers on advancing its therapeutic candidates through clinical trials with the objective of licensing them out to global partners.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for PharmAbcine Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-16 00:00
Delisting Announcement
[기재정정]기타경영사항(자율공시) (상장폐지결정효력정지 가처분 신청)
Korean 12.1 KB
2025-08-19 00:00
Regulatory News Service
투자판단관련주요경영사항 (PMC-309 독점실시권 라이선스 계약(기술이전 계약))
Korean 10.0 KB
2025-08-19 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(자율공시:일정금액미만의청구) (위약벌청구의 소)
Korean 8.7 KB

Automate Your Workflow. Get a real-time feed of all PharmAbcine Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PharmAbcine Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
H. Lundbeck A Logo
Develops and commercializes innovative therapeutics for brain diseases globally.
Denmark HLUN
Global provider of medical aesthetic solutions like botulinum toxin and HA fillers.
South Korea 145020
Human Stem Cells Institute PJSC Logo
A biotech investor developing gene therapy, regenerative medicine, and genetic services.
Russian Federation ISKJ
HUMASIS CO., LTD. Logo
Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.
South Korea 205470
Humedix Co., Ltd. Logo
Develops hyaluronic acid-based pharma, aesthetics, medical devices, and offers CMO services.
South Korea 200670
HUONS CO., LTD. Logo
Global healthcare company providing pharmaceuticals, medical devices, and wellness products.
South Korea 243070
Huons Global Co., Ltd. Logo
Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.
South Korea 084110
Hong Kong N/A
HWAIL PHARM. CO., LTD Logo
Develops and manufactures APIs, finished drugs, and functional ingredients for healthcare.
South Korea 061250
Hyloris Pharmaceuticals SA Logo
A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.
Belgium HYL

Talk to a Data Expert

Have a question? We'll get back to you promptly.